CYTOTUNE
Live / Registered — Registered — Section 71 accepted (as of 13 Jul 2022)
What this means for you
Registered since 07 Feb 2012. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79089375
- Registration number
- 4095058
- Mark type
- Stylized text
- Filed
- 02 Jul 2010
- Published for opposition
- 22 Nov 2011
- Registered
- 07 Feb 2012
- Attorney of record
- Stacey R. Halpern
Goods and services
- Class 001 — Chemicals: Chemical reagents not for medical or veterinary purposes; [ protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicals, namely, polypeptides for in vitro and in vivo scientific and research use; ] biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research use [ ; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific research, reagents, cosmetics, and pharmaceuticals ]
- Class 005 — Pharmaceuticals: [ Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancer, critical limb ischemia, cystic fibrosis, retinitis pigmentosa, AIDS, influenza, and Alzheimer's disease; preparations for gene therapy, namely, introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical purposes; vaccines; gene vaccines; vectors for introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical use, namely, for gene therapy ]
- Class 042 — Scientific and technological services: [ Testing, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuff; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, or development of vaccines; testing, inspection, research, or development of recombinant proteins; medical, chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; testing, inspection, or research related to technologies for manufacturing genetically engineered animals, plants, and vectors; testing, inspection, research, or development of vector technologies, namely, medical and scientific research in the field of genetics and genetic engineering; testing, inspection, or research on agriculture, livestock breeding, or fisheries; testing, inspection, research, or development of chemicals for life science ]
Owner
- ID Pharma Co., Ltd., Tsukuba-shi Ibaraki, JP
- DNAVEC CORPORATION, JP
- DNAVEC CORPORATION, JP
Prosecution history
- 03 May 2025 — Further Decision Processed by IB
- 07 Mar 2025 — GENERIC MADRID TRANSACTION SENT TO IB
- 07 Mar 2025 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 07 Mar 2025 — GENERIC MADRID TRANSACTION CREATED
- 13 Mar 2023 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 13 Jul 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 13 Jul 2022 — REGISTERED-SEC.71 ACCEPTED
- 11 Jul 2022 — TEAS SECTION 71 RECEIVED
- 07 Feb 2021 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 14 Sept 2020 — INTERNATIONAL REGISTRATION RENEWED
- 06 Dec 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 10 May 2019 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 19 Mar 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 19 Mar 2019 — INVALIDATION PROCESSED
- 13 Mar 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED